highperformr logo

AstraZeneca's Overview

Total employees89900
HeadquartersCambridge
Founded1999

AstraZeneca PLC is a British-Swedish multinational pharmaceutical and biotechnology company with its global headquarters in Cambridge, England. It focuses on the discovery, development, manufacture, and commercialization of prescription medicines, primarily for the treatment of diseases in three main therapy areas: Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. AstraZeneca also has a significant presence in rare diseases following its acquisition of Alexion. The company is driven by science and innovation to deliver life-changing medicines to patients worldwide.

Where is AstraZeneca's Headquarters?

HQ Function

Serves as the global corporate headquarters and a strategic R&D hub, driving innovation and global operations.

Notable Features:

The Discovery Centre (DISC), a state-of-the-art facility with open-plan laboratories designed to foster collaboration. Features advanced robotics, high-throughput screening, and sustainable design elements like ground source heat pumps and green roofs.

Work Culture:

A science-led, innovative, and collaborative environment. The Cambridge HQ fosters interaction with the vibrant Cambridge life sciences ecosystem, encouraging a culture of continuous learning and patient-centric research.

HQ Significance:

The Cambridge HQ centralizes much of AstraZeneca's UK-based R&D, enhancing collaboration and accelerating drug discovery. Its location within the Cambridge Biomedical Campus facilitates partnerships with leading academic and research institutions.

Values Reflected in HQ: The HQ design and location reflect AstraZeneca's commitment to scientific leadership, innovation, collaboration, sustainability, and being a great place to work.

Location:

AstraZeneca has a significant global presence, operating in over 100 countries. Its functions are supported globally through strategic R&D centers in the UK (Cambridge), USA (Gaithersburg, MD), and Sweden (Gothenburg). The company also has numerous manufacturing sites strategically located across the world and commercial operations spanning Europe, the Americas, Asia, Africa, and Australia. This extensive network supports the discovery, development, manufacturing, and commercialization of medicines worldwide.

Street Address:

1 Francis Crick Avenue, Cambridge Biomedical Campus

City:

Cambridge

State/Province:

Cambridgeshire

Country:

United Kingdom

AstraZeneca's Global Presence

Gaithersburg, Maryland, USA

Address: One MedImmune Way, Gaithersburg, MD 20878, USA

Serves as a critical hub for AstraZeneca's research and clinical development in North America, leveraging the biotech ecosystem in the Washington D.C. / Maryland region.

Gothenburg, Sweden

Address: Pepparedsleden 1, 431 83 Mölndal, Sweden

Key research and development site in Europe, contributing significantly to AstraZeneca's pipeline and fostering collaboration within the Nordic life science community.

Buying Intent Signals for AstraZeneca

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of AstraZeneca

As of April 2025, AstraZeneca' leadership includes:

Pascal Soriot - Chief Executive Officer
Aradhana Sarin - Chief Financial Officer
Sharon Barr - Executive Vice-President, BioPharmaceuticals R&D
Susan Galbraith - Executive Vice-President, Oncology R&D
Pam Cheng - Executive Vice-President, Global Operations & IT and Chief Sustainability Officer
Dave Fredrickson - Executive Vice-President, Oncology Business Unit
Ruud Dobber - Executive Vice-President, BioPharmaceuticals Business Unit

Investors of AstraZeneca

AstraZeneca has been backed by several prominent investors over the years, including:

BlackRock, Inc.
The Vanguard Group, Inc.
Investor AB
Wellington Management Group LLP
Capital Research Global Investors
State Street Global Advisors

Executive New Hires/Exits in the Last 12 Months

Hire2
Exits2

Over the past year, AstraZeneca has seen key leadership transitions, notably in its R&D division with the retirement of Sir Mene Pangalos and appointment of Sharon Barr. The company also announced a new Chair Designate for the Board and saw the retirement of its Chief Strategy Officer.

Departures

Sir Mene Pangalos, Sir Mene Pangalos retired as EVP, BioPharmaceuticals R&D.
Marc Dunoyer, Marc Dunoyer retired as Chief Strategy Officer and CEO of Alexion.

New Appointments:

Sharon Barr, Sharon Barr appointed as new EVP, BioPharmaceuticals R&D.
Andy Bird, Andy Bird appointed as Chair Designate, to become Chair post-AGM 2024.

Technology (Tech Stack) used by AstraZeneca

Discover the tools AstraZeneca uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

AstraZeneca Email Formats and Examples

AstraZeneca commonly uses the 'firstname.lastname' email format. This is a standard and widely adopted pattern within the company for professional communication.

firstname.lastname@astrazeneca.com

Format

jane.doe@astrazeneca.com

Example

95%

Success rate

News and media

AstraZeneca Press ReleaseMay 2, 2024

AstraZeneca Q1 2024 Results: Strong start to 2024 with total revenue growth of 19%

AstraZeneca announced its financial results for the first quarter of 2024, reporting a 19% increase in total revenue at constant exchange rates. Growth was driven by strong performance across its oncology and biopharmaceuticals portfolio, including its rare disease medicines....more

AstraZeneca Press ReleaseFebruary 16, 2024

TAGRISSO® with chemotherapy approved in the US for EGFR-mutated advanced lung cancer

AstraZeneca's TAGRISSO (osimertinib) in combination with chemotherapy was approved in the US for the treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC). This approval is based on the FLAURA2 Phase III trial results....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including AstraZeneca, are just a search away.